Cantai Therapeutics

Philadelphia, United States

Cantai Therapeutics operates as a developer of drug candidates.

$3.5M raised

Jul 2025

Seed

Life Science Medical

Top Investors

Agent Capital 82VS Tellus BioVentures

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Cantai Therapeutics

How much funding has Cantai Therapeutics raised?

Cantai Therapeutics has raised $3.5M in total funding. The most recent round was Seed. The last funding was announced in July 2025.

Who are Cantai Therapeutics's investors?

Cantai Therapeutics's investors include Agent Capital, 82VS, Tellus BioVentures.

Where is Cantai Therapeutics headquartered?

Cantai Therapeutics is headquartered in Philadelphia, United States.

What does Cantai Therapeutics do?

Cantai Therapeutics operates as a developer of drug candidates.

What stage is Cantai Therapeutics at?

Cantai Therapeutics is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated July 15, 2025.

MLA

"Cantai Therapeutics — Funding & Investors." VCBacked, July 15, 2025, https://www.vcbacked.co/company/cantai-therapeutics. Accessed July 2, 2026.

APA

VCBacked. (2025). Cantai Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/cantai-therapeutics

Wikipedia (cite web)

{{cite web |title=Cantai Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/cantai-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated July 15, 2025.

Similar Companies in Life Science

Neuroglee Therapeutics

Singapore$10.0M

Navrogen

Philadelphia